(MRD) Melcor Developments - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA5854671032

MRD: Real Estate, Properties, Golf Courses, Land, Retail Centers

Melcor Developments Ltd. (MRD) is a prominent real estate development company with operations spanning the United States and Canada. Established in 1923 and headquartered in Edmonton, Canada, Melcor operates through four primary divisions: Land, Properties, REIT, and Golf. The company specializes in developing, owning, and managing a diverse portfolio of mixed-use residential communities, business and industrial parks, office buildings, retail centers, and golf courses. Additionally, Melcor engages in purchasing and developing land for residential, industrial, and commercial lots, and leases properties across retail, office, and industrial sectors. The company also owns and manages 18-hole golf courses and clubs, enhancing its recreational offerings. As a subsidiary of Melton Holdings Ltd., Melcor is strategically positioned to leverage its extensive experience and resources in the real estate sector.

From a technical standpoint, MRDs stock has shown a short-term downtrend, with the last price of 12.76 slightly below the SMA 20 of 12.86. The SMA 50 and SMA 200 are at 12.72 and 12.37, respectively, indicating a potential longer-term downtrend. The ATR of 0.22 suggests low volatility, which may imply stable price movements. Fundamentally, MRDs market cap is 401.50M CAD, with a high P/E of 34.76 and a lower forward P/E of 5.59, hinting at expected growth. The P/B ratio of 0.32 indicates undervaluation relative to book value, while the P/S of 1.32 reflects moderate revenue generation. The RoE of 0.95 suggests modest profitability.

3-Month Forecast: - Price Range: MRDs stock price is expected to fluctuate between 12.40 and 13.20 CAD over the next three months, influenced by the convergence of SMA 20 and SMA 50. - Volatility: Anticipate low volatility with average price movements of 0.22 CAD, as indicated by the ATR. - Potential Recovery: The low P/B ratio and favorable forward P/E suggest potential for recovery, possibly reaching the upper range of 13.20 CAD.

Additional Sources for MRD Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MRD Stock Overview

Market Cap in USD 279m
Sector Real Estate
Industry Real Estate - Development
GiC Sub-Industry Real Estate Development
IPO / Inception

MRD Stock Ratings

Growth 5y 52.1%
Fundamental 10.8%
Dividend 60.6%
Rel. Strength Industry 0.57
Analysts -
Fair Price Momentum 12.22 CAD
Fair Price DCF 48.38 CAD

MRD Dividends

Dividend Yield 12m 3.63%
Yield on Cost 5y 6.09%
Annual Growth 5y 5.29%
Payout Consistency 89.7%

MRD Growth Ratios

Growth Correlation 3m -6.3%
Growth Correlation 12m 78%
Growth Correlation 5y 55%
CAGR 5y 10.74%
CAGR/Max DD 5y 0.25
Sharpe Ratio 12m -0.26
Alpha 2.32
Beta 0.25
Volatility 24.92%
Current Volume 8.7k
Average Volume 20d 7.2k
What is the price of MRD stocks?
As of March 17, 2025, the stock is trading at CAD 12.00 with a total of 8,652 shares traded.
Over the past week, the price has changed by -0.50%, over one month by -5.59%, over three months by -5.81% and over the past year by +10.55%.
Is Melcor Developments a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Melcor Developments is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.84 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRD as of March 2025 is 12.22. This means that MRD is currently overvalued and has a potential downside of 1.83%.
Is MRD a buy, sell or hold?
Melcor Developments has no consensus analysts rating.
What are the forecast for MRD stock price target?
According to ValueRays Forecast Model, MRD Melcor Developments will be worth about 13.2 in March 2026. The stock is currently trading at 12.00. This means that the stock has a potential upside of +10%.
Issuer Forecast Upside
Wallstreet Target Price 14 16.7%
Analysts Target Price - -
ValueRay Target Price 13.2 10%